Hessling, K., Brand, C., Schwöppe, C., Gerwing, M., Pavelka, S., Berdel, A. F., Hintelmann, H., Hamacher, R., Müller-Tidow, C., Egerer, G., Hartmann, W., Grünewald, I., Lindner, L. H., Gioia, D. D., Hecker, J. S., Maurer, S., Pink, D., Fried, M., Bonilla, S. A. Z., Scheuble, A., Lordick, F., Ivanyi, P., Fobker, M., Lenz, G., Gerss, J., Kessler, T., Berdel, W. E., Schliemann, C. (2026). Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacy. Scientific Reports. https://doi.org/10.1038/s41598-026-40362-4